Literature DB >> 17486304

[Clinical course and therapy of lymphomatoid papulosis. Experience with 17 cases and literature review].

D Korpusik1, T Ruzicka.   

Abstract

Lymphomatoid papulosis is a rare disease with a worldwide incidence of 1.2 to 1.9 per 1 million. It affects all age groups with a peak incidence between 30 and 40 years and an apparent male predominance. Occurrence in childhood has also been described. Both the etiology and pathogenesis of the disease are unknown. The clinical presentation is extremely variable and frequently uncharacteristic. A papulonodular eruption, characterized by self-healing skin lesions appearing in crops can often be seen, particularly on extremities. We report on 17 patients, including 2 children. By detailing 6 cases we point out the variable morphologic manifestations, the different courses of disease and therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486304     DOI: 10.1007/s00105-007-1295-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  40 in total

1.  Pathology case of the month. A recurrent vesicle on the plantar aspect of the foot. Primary cutaneous CD30- positive T-cell lymphoproliferative disorder, consistent with lymphomatoid papulosis.

Authors:  Rachel B Flamholz; Diana M Veillon; Mary L Nordberg; James D Cotelingam
Journal:  J La State Med Soc       Date:  2004 Jan-Feb

2.  Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.

Authors:  J A Kummer; M H Vermeer; D Dukers; C J Meijer; R Willemze
Journal:  J Invest Dermatol       Date:  1997-11       Impact factor: 8.551

3.  An atypical presentation of lymphomatoid papulosis.

Authors:  Vered Molho-Pessach; Alex Maly; Arieh Ingber
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

4.  [Slowly developing and clinically benign reticulopathy with extremely malignant histological structure].

Authors:  A Dupont
Journal:  Hautarzt       Date:  1965-06       Impact factor: 0.751

5.  Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases.

Authors:  T Basarab; E A Fraser-Andrews; G Orchard; S Whittaker; R Russel-Jones
Journal:  Br J Dermatol       Date:  1998-10       Impact factor: 9.302

Review 6.  Localized lymphomatoid papulosis.

Authors:  M Kagaya; S Kondo; A Kamada; Y Yamada; H Matsusaka; K Jimbow
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

Review 7.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

8.  Granulomatous eccrinotropic lymphomatoid papulosis.

Authors:  A Neil Crowson; Dmitry Y Baschinsky; Al Kovatich; Cynthia Magro
Journal:  Am J Clin Pathol       Date:  2003-05       Impact factor: 2.493

9.  Ki-1 (CD30) expression in differentiation of lymphomatoid papulosis from arthropod bite reactions.

Authors:  B R Smoller; T A Longacre; R A Warnke
Journal:  Mod Pathol       Date:  1992-09       Impact factor: 7.842

10.  The clinical and histological spectrum of lymphomatoid papulosis.

Authors:  R Willemze; C J Meyer; W A Van Vloten; E Scheffer
Journal:  Br J Dermatol       Date:  1982-08       Impact factor: 9.302

View more
  2 in total

1.  [Lymphomatoid papulosis in a 2 1/2-year-old boy].

Authors:  P M Amann; M Megahed
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

Review 2.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.